MONONUCLEAR THERAPEUTICS Trademark

Trademark Overview


On Friday, December 7, 2018, a trademark application was filed for MONONUCLEAR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MONONUCLEAR THERAPEUTICS trademark a serial number of 88221539. The federal status of this trademark filing is REGISTERED as of Tuesday, September 8, 2020. This trademark is owned by Mononuclear Therapeutics Limited. The MONONUCLEAR THERAPEUTICS trademark is filed in the Transportation & Storage Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Storage and retrieval of blood, tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research; biomedical services namely, the storage of human cells, specifically umbilical cord blood, umbilical cord blood cells, and stem cells for medical use and research use

Collection and testing of cord blood, blood, blood components, tissue and stem cells for medical research; medical diagnostic testing relating to cord blood, placenta tissue, human body

Research and development services in cellular therapy, in particularly, research and development in the field of treatment and medical diagnosis using cellular, molecular, biotechnological and genetic methods, and in the field of development of mononuclear cell therapy; research and development of individualized medicine, development of treatment plan and therapy adapted for individual patients; biomedical laboratory services for others, namely, the collection, extraction, processing, cryopreservation, analysis, screening, testing, typing and storage of umbilical cord blood, placenta, human tissues and stem cells; genetic testing services for research purposes; consultation, research and development relating to scientific research; research and development relating to medicine and healthcare products; development of testing methods in the fields of cellular therapy and mononuclear cell therapy
mononuclear therapeutics

General Information


Serial Number88221539
Word MarkMONONUCLEAR THERAPEUTICS
Filing DateFriday, December 7, 2018
Status700 - REGISTERED
Status DateTuesday, September 8, 2020
Registration Number6148263
Registration DateTuesday, September 8, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements


Description of MarkThe mark consists of a design in the form of a small, shaded circle enclosed within two larger, concentric circles, the outer of which has an indent at the top which contains a small, shaded circle. The words "MONONUCLEAR THERAPEUTICS" are to the right of the design with "MONONUCLEAR" in bold above "THERAPEUTICS".
Goods and ServicesStorage and retrieval of blood, tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research; biomedical services namely, the storage of human cells, specifically umbilical cord blood, umbilical cord blood cells, and stem cells for medical use and research use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCollection and testing of cord blood, blood, blood components, tissue and stem cells for medical research; medical diagnostic testing relating to cord blood, placenta tissue, human body
Disclaimer with Predetermined Text"MONONUCLEAR THERAPEUTICS"
Goods and ServicesResearch and development services in cellular therapy, in particularly, research and development in the field of treatment and medical diagnosis using cellular, molecular, biotechnological and genetic methods, and in the field of development of mononuclear cell therapy; research and development of individualized medicine, development of treatment plan and therapy adapted for individual patients; biomedical laboratory services for others, namely, the collection, extraction, processing, cryopreservation, analysis, screening, testing, typing and storage of umbilical cord blood, placenta, human tissues and stem cells; genetic testing services for research purposes; consultation, research and development relating to scientific research; research and development relating to medicine and healthcare products; development of testing methods in the fields of cellular therapy and mononuclear cell therapy

Classification Information


International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateSunday, December 30, 2018
Primary Code039
First Use Anywhere DateFriday, November 1, 2019
First Use In Commerce DateFriday, November 1, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, December 30, 2018
Primary Code042
First Use Anywhere DateFriday, November 1, 2019
First Use In Commerce DateFriday, November 1, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 7, 2019
Primary Code044
First Use Anywhere DateFriday, November 1, 2019
First Use In Commerce DateFriday, November 1, 2019

Trademark Owner History


Party NameMononuclear Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Party NameMononuclear Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Party NameMononuclear Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Trademark Events


Event DateEvent Description
Thursday, December 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 8, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, August 1, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 31, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 8, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 17, 2020USE AMENDMENT FILED
Wednesday, July 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 17, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, January 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 18, 2019ASSIGNED TO LIE
Sunday, September 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 14, 2019EXAMINER'S AMENDMENT ENTERED
Saturday, September 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, September 14, 2019EXAMINERS AMENDMENT E-MAILED
Saturday, September 14, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, September 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 6, 2019ASSIGNED TO EXAMINER
Tuesday, January 1, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, December 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 11, 2018NEW APPLICATION ENTERED IN TRAM